Research led by Professor Sehamuddin Galadari at NYU Abu Dhabi has identified the tumor suppressor protein Par-4 as a key player in inducing a unique type of cell death called ferroptosis in human glioblastoma cells, while sparing healthy cells. Ferroptosis is triggered by iron-mediated production of reactive oxygen species (ROS) and lipid peroxidation, which can shrink cancerous tumors. This finding has significant implications for developing novel treatments for hard-to-treat cancers and neurodegenerative diseases, as Par-4 has been shown to promote ferroptosis alongside its known role in apoptosis.
The study, published in Communications Biology, revealed that Par-4 activates autophagy-dependent ferroptosis through the nuclear receptor co-activator 4 (NCOA4) in glioblastoma cells. This activation leads to the accumulation of the labile iron pool, production of ROS, and lipid peroxidation, ultimately resulting in ferroptosis-mediated cancer regression. Ferroptosis is a critical process in various health issues, including cancer, heart disease, brain damage, kidney failure, lung injury, and neurodegenerative diseases like Parkinson’s, Huntington’s, and Alzheimer’s. Identifying Par-4’s role in ferroptosis is crucial for understanding and targeting this alternative cell death pathway in cancer treatment.
The tumor suppressor protein Par-4 is expressed across species but is often reduced, mutated, or inactivated in cancers. The team’s discovery of Par-4’s role in triggering ferroptosis is a breakthrough in cancer treatment development. This research was a collaborative effort between Professor Mazin Magzoub’s lab at NYU Abu Dhabi and Professor Vivek M. Rangnekar from the University of Kentucky, who discovered Par-4 in 1993. Developing methods to activate alternative cell death pathways presents new opportunities for creating more potent and effective therapies for glioblastoma and other deadly diseases that don’t respond to current treatments or have developed resistance to existing therapies.
Galadari, the Senior Vice Provost for Research and Managing Director of the Research Institute at NYU Abu Dhabi, emphasized the importance of investing in research at institutions like NYUAD for transforming the UAE into a knowledge-based economy that attracts local, regional, and global talent. This symbiotic relationship fosters opportunities, knowledge, and wealth creation through groundbreaking discoveries like the role of Par-4 in promoting ferroptosis in cancer cells. The potential to develop novel treatments targeting ferroptosis opens up new avenues for more effective therapies in glioblastoma and other challenging diseases.
The findings from this study provide insights into the mechanisms of ferroptosis and the potential for targeting this alternative cell death pathway in various diseases. By understanding how Par-4 activates autophagy-dependent ferroptosis in glioblastoma cells, researchers can explore new treatment strategies that leverage this process to selectively induce cancer cell death while sparing healthy cells. This research highlights the importance of uncovering the molecular pathways involved in alternative cell death mechanisms, such as ferroptosis, to develop more precise and effective therapies for hard-to-treat cancers and neurodegenerative diseases like glioblastoma.
In conclusion, the discovery of Par-4’s role in promoting ferroptosis in glioblastoma cells represents a significant advancement in cancer treatment development. By activating alternative cell death pathways like ferroptosis, researchers have the potential to create more potent and effective therapies for challenging cancers and neurodegenerative diseases. Collaborative research efforts between institutions like NYU Abu Dhabi and the University of Kentucky underscore the importance of investing in scientific research to drive innovation and knowledge creation, ultimately leading to new opportunities for improving human health and well-being.
